• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 在开发针对 COVID-19 的潜在治疗靶点中的作用:叙事性综述。

MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.

机构信息

Department of Pathology and Microbiology, University of Duhok, Kurdistan Region, Iraq.

Department of Biology, College of Education, Salahaddin University-Erbil, Kurdistan Region, Iraq.

出版信息

J Infect Public Health. 2022 Jul;15(7):788-799. doi: 10.1016/j.jiph.2022.06.012. Epub 2022 Jun 21.

DOI:10.1016/j.jiph.2022.06.012
PMID:35751930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9221922/
Abstract

BACKGROUND

As the therapeutic regimens against the COVID-19 remain scarce, the microRNAs (miRNAs) can be exploited to generate efficient therapeutic targets. The miRNAs have been found to play pivotal roles in the several regulatory functions influencing the prognosis of viral infection. The miRNAs have a prospective role in the up and down regulation of the ACE2 receptors. This review examines the clinical applications, as well as the possible threats associated with the use of miRNAs to combat the deleterious consequences of SARS-CoV-2 infection.

METHODOLOGY

This article was compiled to evaluate how the miRNAs are involved in the SARS-CoV-2 pathogenesis and infection, and their potential functions which could help in the development of therapeutic targets against the COVID-19. The sources of the collected information include the several journals, databases and scientific search engines such as the Google scholar, Pubmed, Science direct, official website of WHO, among the other sites. The investigations on the online platform were conducted using the keywords miRNA biogenesis, miRNA and ACE2 interaction, therapeutic role of miRNAs against SARS-CoV-2 and miRNA therapy side effects.

RESULTS

This review has highlighted that the miRNAs can be exploited to generate potential therapeutic targets against the COVID-19. Changes in the miRNA levels following viral replication are an essential component of the host response to infection. The collection and modification of miRNA modulates may help to minimize the deleterious consequences of SARS-CoV-2 infection, such as by controlling or inhibiting the generation of cytokines and chemokines. The degradation of viral RNA by the cellular miRNAs, along with the reduced expression of ACE2 receptors, can substantially reduce the viral load. Specific miRNAs have been found to have an antiviral influence, allowing the immune system to combat the infection or forcing the virus into a latency stage.

CONCLUSION

This review summarizes several studies revealing the involvement of miRNAs in diverse and complex processes during the infection process of SARS-CoV-2. The miRNAs can substantially reduce the viral load by degradation of viral RNA and reduced expression of ACE2 receptors, besides mitigating the deleterious consequences of the exaggerated secretion of cytokines. Extensive investigations need to be done by the scientific community to utilize the miRNA based strategies for the development of effective therapeutic targets against the COVID-19.

摘要

背景

由于针对 COVID-19 的治疗方案仍然很少,因此可以利用 microRNAs(miRNAs)来生成有效的治疗靶标。已经发现 miRNAs 在影响病毒感染预后的几种调节功能中发挥着关键作用。miRNAs 在 ACE2 受体的上调和下调中具有前瞻性作用。本综述检查了 miRNA 在对抗 SARS-CoV-2 感染的有害后果方面的临床应用以及可能存在的威胁。

方法

本文旨在评估 miRNAs 如何参与 SARS-CoV-2 的发病机制和感染,以及它们可能有助于开发针对 COVID-19 的治疗靶标的潜在功能。收集信息的来源包括几家期刊、数据库和科学搜索引擎,如 Google Scholar、PubMed、Science Direct、世界卫生组织官方网站等。在在线平台上的调查使用了 miRNA 生物发生、miRNA 与 ACE2 相互作用、miRNA 对抗 SARS-CoV-2 的治疗作用以及 miRNA 治疗副作用等关键词。

结果

本综述强调,miRNAs 可用于生成针对 COVID-19 的潜在治疗靶标。病毒复制后 miRNA 水平的变化是宿主对感染反应的重要组成部分。miRNA 修饰的收集和修饰可能有助于最大程度地减少 SARS-CoV-2 感染的有害后果,例如通过控制或抑制细胞因子和趋化因子的产生。细胞 miRNAs 对病毒 RNA 的降解以及 ACE2 受体表达的降低,可大大降低病毒载量。已经发现特定的 miRNAs 具有抗病毒作用,使免疫系统能够对抗感染或迫使病毒进入潜伏期。

结论

本综述总结了几项研究,这些研究揭示了 miRNAs 在 SARS-CoV-2 感染过程中的多种复杂过程中的参与。miRNAs 通过降解病毒 RNA 和降低 ACE2 受体的表达,可大大降低病毒载量,减轻细胞因子过度分泌的有害后果。科学界需要进行广泛的研究,以利用基于 miRNA 的策略开发针对 COVID-19 的有效治疗靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ca2/9221922/8b3ad7b771ea/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ca2/9221922/3ce82e506705/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ca2/9221922/471b577ad9cb/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ca2/9221922/0cc9f3f3981f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ca2/9221922/8b3ad7b771ea/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ca2/9221922/3ce82e506705/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ca2/9221922/471b577ad9cb/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ca2/9221922/0cc9f3f3981f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ca2/9221922/8b3ad7b771ea/gr4_lrg.jpg

相似文献

1
MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.微小 RNA 在开发针对 COVID-19 的潜在治疗靶点中的作用:叙事性综述。
J Infect Public Health. 2022 Jul;15(7):788-799. doi: 10.1016/j.jiph.2022.06.012. Epub 2022 Jun 21.
2
The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.microRNAs 在调节人类细胞中 SARS-CoV-2 感染中的作用:系统评价。
Infect Genet Evol. 2021 Jul;91:104832. doi: 10.1016/j.meegid.2021.104832. Epub 2021 Apr 1.
3
Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.宿主 microRNAs 对 SARS-CoV-2、病毒进入蛋白 ACE2 和 TMPRSS2 及干扰素基因的靶向计算分析。
Genes (Basel). 2020 Nov 16;11(11):1354. doi: 10.3390/genes11111354.
4
MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.MicroRNA 模拟物或抑制剂作为针对 COVID-19 的抗病毒治疗方法。
Drugs. 2021 Apr;81(5):517-531. doi: 10.1007/s40265-021-01474-5. Epub 2021 Feb 27.
5
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?microRNAs 在 COVID-19 中作为生物标志物和治疗靶点的潜在功能是什么?
Infect Genet Evol. 2020 Nov;85:104417. doi: 10.1016/j.meegid.2020.104417. Epub 2020 Jun 8.
6
Potential COVID-19 therapeutic approaches targeting angiotensin-converting enzyme 2; An updated review.针对血管紧张素转化酶 2 的潜在 COVID-19 治疗方法;最新综述。
Rev Med Virol. 2022 Jul;32(4):e2321. doi: 10.1002/rmv.2321. Epub 2021 Dec 27.
7
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
8
The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection.miRNAs 在 COVID-19 发病机制中的新作用:植物营养素多酚化合物对 SARS-CoV-2 感染的保护作用。
Int J Med Sci. 2022 Jul 18;19(8):1340-1356. doi: 10.7150/ijms.76168. eCollection 2022.
9
Cellular microRNAs target SARS-CoV-2 spike protein and restrict viral replication.细胞 microRNAs 靶向 SARS-CoV-2 刺突蛋白并限制病毒复制。
Am J Physiol Cell Physiol. 2023 Aug 1;325(2):C420-C428. doi: 10.1152/ajpcell.00516.2022. Epub 2023 Jul 3.
10
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3--gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases.绿茶儿茶素(-)-表没食子儿茶素-3-没食子酸酯(EGCG)在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中的治疗潜力:与宿主/病毒蛋白酶的主要相互作用
Phytomed Plus. 2023 Feb;3(1):100402. doi: 10.1016/j.phyplu.2022.100402. Epub 2022 Dec 30.

引用本文的文献

1
Genetic and Inflammatory Signatures Associated With Worse Prognosis in Hospitalized Patients With Severe SARS-CoV-2 Infection With and Without Diabetes.伴有和不伴有糖尿病的重症SARS-CoV-2感染住院患者中与预后较差相关的遗传和炎症特征。
J Med Virol. 2025 Jun;97(6):e70425. doi: 10.1002/jmv.70425.
2
Selective inhibition of rabies virus gene expression by human miRNAs: a therapeutic approach using the 7mer-m8 model.人源微小RNA对狂犬病病毒基因表达的选择性抑制:一种使用7mer-m8模型的治疗方法
Virus Genes. 2025 Apr 15. doi: 10.1007/s11262-025-02155-1.
3
The impact of ivermectin on COVID-19 outcomes: a systematic review and meta-analysis.

本文引用的文献

1
SARS-COV-2 as potential microRNA sponge in COVID-19 patients.SARS-CoV-2 作为 COVID-19 患者中的潜在 miRNA 海绵。
BMC Med Genomics. 2022 Apr 23;15(Suppl 2):94. doi: 10.1186/s12920-022-01243-7.
2
Profiling Levels of Serum microRNAs and Soluble ACE2 in COVID-19 Patients.新型冠状病毒肺炎患者血清微小核糖核酸和可溶性血管紧张素转换酶2水平分析
Life (Basel). 2022 Apr 12;12(4):575. doi: 10.3390/life12040575.
3
The role of microRNAs in COVID-19 with a focus on miR-200c.微小RNA在新型冠状病毒肺炎中的作用,重点关注miR-200c
伊维菌素对COVID-19结局的影响:一项系统评价和荟萃分析。
Ann Med Surg (Lond). 2025 Jan 7;87(2):809-829. doi: 10.1097/MS9.0000000000002762. eCollection 2025 Feb.
4
Decoding the intricacies: a comprehensive analysis of microRNAs in the pathogenesis, diagnosis, prognosis and therapeutic strategies for COVID-19.解读复杂之处:对新冠病毒在发病机制、诊断、预后及治疗策略方面的微小RNA进行全面分析
Front Med (Lausanne). 2024 Oct 7;11:1430974. doi: 10.3389/fmed.2024.1430974. eCollection 2024.
5
Advanced biomaterials for regenerative medicine and their possible therapeutic significance in treating COVID-19: a critical overview.用于再生医学的先进生物材料及其在治疗新冠肺炎中的潜在治疗意义:批判性综述
Int J Surg. 2024 Dec 1;110(12):7508-7527. doi: 10.1097/JS9.0000000000002110.
6
Clinical outcomes following hospitalization for COVID-19 in patients with cardiac sarcoidosis in the United States: a propensity-matched analysis from national inpatient sample database from April 2020 to December 2021.美国心脏结节病患者 COVID-19 住院后的临床结局:一项基于 2020 年 4 月至 2021 年 12 月国家住院样本数据库的倾向匹配分析
Ann Med Surg (Lond). 2024 Aug 22;86(10):5696-5703. doi: 10.1097/MS9.0000000000002474. eCollection 2024 Oct.
7
The relationship between microRNAs and COVID-19 complications.微小RNA与新型冠状病毒肺炎并发症之间的关系。
Noncoding RNA Res. 2024 Aug 22;10:16-24. doi: 10.1016/j.ncrna.2024.08.007. eCollection 2025 Feb.
8
Human cytomegalovirus microRNAs: strategies for immune evasion and viral latency.人巨细胞病毒 microRNAs:免疫逃避和病毒潜伏的策略。
Arch Virol. 2024 Jul 6;169(8):157. doi: 10.1007/s00705-024-06080-w.
9
The impact of COVID-19 on microRNA and CD marker expression in AML patients.COVID-19 对 AML 患者中 microRNA 和 CD 标志物表达的影响。
Sci Rep. 2024 Jun 20;14(1):14251. doi: 10.1038/s41598-024-64775-1.
10
Impact of COVID-19 Pandemic on Routine Childhood Immunization Programs in Indonesia: Taking Rural and Urban Area into Account.新冠疫情对印度尼西亚儿童常规免疫规划的影响:兼顾农村和城市地区
Patient Prefer Adherence. 2024 Mar 13;18:667-675. doi: 10.2147/PPA.S448901. eCollection 2024.
J Circ Biomark. 2022 Mar 21;11:14-23. doi: 10.33393/jcb.2022.2356. eCollection 2022 Jan-Dec.
4
Coronavirus disease 2019 and mRNA vaccines: what's next - miRNA?2019冠状病毒病与mRNA疫苗:接下来是什么——微小RNA?
Clin Exp Pediatr. 2022 Jun;65(6):302-303. doi: 10.3345/cep.2022.00283. Epub 2022 Mar 28.
5
Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm.针对细胞因子风暴的基于核酸的新冠病毒治疗:平息风暴的策略
J Pers Med. 2022 Mar 3;12(3):386. doi: 10.3390/jpm12030386.
6
A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19.新型冠状病毒肺炎与社区获得性肺炎患者循环 miRNA 和细胞因子的差异特征揭示了新型冠状病毒肺炎的新病理生理机制。
Front Immunol. 2022 Jan 11;12:815651. doi: 10.3389/fimmu.2021.815651. eCollection 2021.
7
Immunomodulatory and therapeutic implications of vitamin D in the management of COVID-19.维生素 D 在 COVID-19 管理中的免疫调节和治疗意义。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2025734. doi: 10.1080/21645515.2022.2025734. Epub 2022 Jan 24.
8
Will the next spillover pandemic be deadlier than the COVID-19?: A wake-up call.下一次溢出性大流行会比新冠疫情更致命吗?警钟敲响。
Int J Surg. 2022 Jan;97:106208. doi: 10.1016/j.ijsu.2021.106208. Epub 2022 Jan 4.
9
Comparative pathology, molecular pathogenicity, immunological features, and genetic characterization of three highly pathogenic human coronaviruses (MERS-CoV, SARS-CoV, and SARS-CoV-2).三种高致病性人类冠状病毒(中东呼吸综合征冠状病毒、严重急性呼吸综合征冠状病毒和新型冠状病毒)的比较病理学、分子发病机制、免疫学特征和遗传特征。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7162-7184. doi: 10.26355/eurrev_202111_27270.
10
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.微小 RNA 在解决新冠病毒感染到治疗的谜题中的作用:一篇迷你综述。
Virus Res. 2022 Jan 15;308:198631. doi: 10.1016/j.virusres.2021.198631. Epub 2021 Nov 14.